wAll teichoic acids as immUnogenic and conseRved altErnative targets for therapies versUs S. aureus

Project: Research funding

Project Details

AcronymAUREUS
StatusActive
Effective start/end date1/02/2531/01/29

Collaborative partners

  • University of Vienna
  • Università degli studi di Napoli Federico II (lead)
  • Leiden University
  • Imperial College London
  • VU University Medical Center Amsterdam
  • University of Grenoble Alpes
  • Eberhard Karls Universität Tübingen
  • Centro Nacional de Biotecnologia
  • York University
  • National Institute for Bioprocessing Research and Training
  • GLYcoDiag